Uncategorized
News
Inside the world of trial consulting: news and insights
From media features and firm announcements to expert commentary on emerging trends and developments in the field of trial strategy and jury consulting, our news and insights offers timely updates for legal professionals navigating high-stakes litigation. Explore how Focus Litigation Consulting’s expertise continues to shape outcomes in courtrooms across the country.
For many years, jury selection relied heavily on demographics. Age, gender, race, education level, and political affiliation were often treated as reliable indicators of how a juror might view a case. The assumption was simple: people tended to “stay in their lanes,” aligning their decisions
Ever wonder why jurors see the same evidence but reach wildly different conclusions? The courtroom is not just a battle of facts; it’s a battle against hidden psychological biases shaping each juror’s interpretation of the evidence. Although jurors are asked to make decisions solely based
What Sean “Diddy” Comb’s Trial Verdict Reveals about Juror Decision-Making In Emotionally Charged, High-Profile Cases The 2025 Sean “Diddy” Combs trial has captivated the public with its blend of celebrities, allegations of violence, and claims of organized sex trafficking. Yet, behind the headlines, the verdict
October 2021 – Senior trial consultant, Dr. Geri Fischman discussed with Law.com how jurors have approached scientific and medical evidence and testimony since the pandemic. She also addresses whether the political polarization surrounding COVID has seeped into the jury pool. A recently refitted courtroom in
September 2021 – The first full day of testimony in the fraud trial of Theranos Inc. founder Elizabeth Holmes on Tuesday is expected to feature prosecution witnesses who will bolster the government’s case against her. The Silicon Valley Business Journal covered the trial, referencing analyses
September 2021 – Theranos Inc. founder Elizabeth Holmes is facing a criminal trial in federal court in San Jose, Calif., on charges that she defrauded investors and patients by lying about the accuracy of her company’s finger-prick blood-testing technology. Holmes has pleaded not guilty to
